Tag: Disease progression
AI Blood Test for Early Parkinson’s Detection: A Promising Breakthrough
A groundbreaking new blood test has been developed using artificial intelligence that could potentially detect Parkinson's disease up to seven years before symptoms appear. The study, conducted by researchers from University College London and...
Experimental Alzheimer’s drug receives FDA advisory panel’s approval: Progress is happeningSEO-friendly title: Alzheimer’s Drug...
An experimental Alzheimer's drug called donanemab received an endorsement from a U.S. Food and Drug Administration (FDA) advisory panel. The drug is intended to target symptoms of early Alzheimer's disease, such as mild cognitive...
Multiple sclerosis patient-derived spontaneous B cells have distinct EBV and host gene expression profiles...
Multiple sclerosis patient-derived spontaneous B cells have distinct EBV and host gene expression profiles in active disease - Nature MicrobiologyIntroduction: In this groundbreaking study, researchers have uncovered unique gene expression profiles in B cells...
Multiple sclerosis: blood test that tracks immune response could be first step in developing...
Unlocking the Mystery Behind Multiple Sclerosis: The Role of Epstein-Barr VirusMultiple sclerosis (MS) affects an estimated 2.8 million people worldwide, causing issues with movement, vision, balance, and sensation. While there is currently no cure...
This New Blood Test Could Help Solve The Mystery of Multiple Sclerosis
New Blood Test Unveiled to Understand Multiple Sclerosis CausesA groundbreaking blood test has been developed to estimate the strength of the immune response in individuals with multiple sclerosis (MS). With an estimated 2.8 million...
Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in...
Breakthrough Results in Metastatic Triple Negative Breast Cancer TreatmentIn a recent study, new positive Phase 2 results have shown meaningful improvement in overall survival (OS) and tolerability for patients with metastatic triple negative breast...